Atezolizumab plus bevacizumab combination for untreated metastatic kidney cancer
Results from this phase III trial of atezolizumab plus bevacizumab [...]
Savolitinib shows promise in first-in-human phase 1 study in solid tumours
Results from a first-in-human phase 1 study of savolitinib in [...]
New drug combination for advanced kidney cancer
Scientists have identified a promising new drug for renal cell [...]
New insights into immune-related adverse events in genitourinary cancers
The following is an interview with Dr Tanya Dorff, Associate Clinical [...]
